[1] Alvimedica’s headquarters are a 5,500 m² facility located at the free trade zone in Catalca, Istanbul, Turkey.
[2] With an area of 700 m², Alvimedica's Good Manufacturing Practice-compliant facility contains the main assembly of catheter and stent systems.
The trial was not powered for significance, but results indicate that endothelial coverage of Coracto at 14 days was better than that of both EES and SES.
[9] Together they provide training for Turkish cardiologists as part of an international project called Stent For Life.
[10] Through the training sessions the partnership aims at the early detecting of heart attacks and then making sure that the patient will receive the necessary treatment within an hour.